Two modes of fusogenic action for influenza virus fusion peptide.


Journal

PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922

Informations de publication

Date de publication:
May 2023
Historique:
received: 15 01 2023
accepted: 11 05 2023
revised: 08 06 2023
medline: 12 6 2023
pubmed: 26 5 2023
entrez: 26 5 2023
Statut: epublish

Résumé

The entry of influenza virus into the host cell requires fusion of its lipid envelope with the host membrane. It is catalysed by viral hemagglutinin protein, whose fragments called fusion peptides become inserted into the target bilayer and initiate its merging with the viral membrane. Isolated fusion peptides are already capable of inducing lipid mixing between liposomes. Years of studies indicate that upon membrane binding they form bend helical structure whose degree of opening fluctuates between tightly closed hairpin and an extended boomerang. The actual way in which they initiate fusion remains elusive. In this work we employ atomistic simulations of wild type and fusion inactive W14A mutant of influenza fusion peptides confined between two closely apposed lipid bilayers. We characterise peptide induced membrane perturbation and determine the potential of mean force for the formation of the first fusion intermediate, an interbilayer lipid bridge called stalk. Our results demonstrate two routes through which the peptides can lower free energy barrier towards fusion. The first one assumes peptides capability to adopt transmembrane configuration which subsequently promotes the creation of a stalk-hole complex. The second involves surface bound peptide configuration and proceeds owing to its ability to stabilise stalk by fitting into the region of extreme negative membrane curvature resulting from its formation. In both cases, the active peptide conformation corresponds to tight helical hairpin, whereas extended boomerang geometry appears to be unable to provide favourable thermodynamic effect. The latter observation offers plausible explanation for long known inactivity of boomerang-stabilising W14A mutation.

Identifiants

pubmed: 37235589
doi: 10.1371/journal.pcbi.1011174
pii: PCOMPBIOL-D-23-00059
pmc: PMC10249882
doi:

Substances chimiques

Hemagglutinin Glycoproteins, Influenza Virus 0
Peptides 0
Lipid Bilayers 0
Peptide Fragments 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1011174

Informations de copyright

Copyright: © 2023 Michalski, Setny. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Proteins. 2014 Sep;82(9):2118-27
pubmed: 24668589
Virology. 2009 Nov 25;394(2):321-30
pubmed: 19755201
Nat Struct Biol. 2001 Aug;8(8):715-20
pubmed: 11473264
Int J Mol Sci. 2020 May 29;21(11):
pubmed: 32485905
J Biol Chem. 1995 Nov 17;270(46):27606-14
pubmed: 7499224
Biophys J. 2004 Jul;87(1):14-22
pubmed: 15240440
J Comput Chem. 2008 Aug;29(11):1859-65
pubmed: 18351591
Protein Pept Lett. 2009;16(7):766-78
pubmed: 19601906
PLoS Comput Biol. 2013;9(3):e1002950
pubmed: 23505359
Int J Mol Sci. 2021 May 18;22(10):
pubmed: 34069905
Virology. 2015 May;479-480:498-507
pubmed: 25866377
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11341-6
pubmed: 20534508
Proteins. 2010 Jun;78(8):1950-8
pubmed: 20408171
J Mol Biol. 2005 Dec 16;354(5):1129-41
pubmed: 16297931
J Biol Chem. 2015 Jan 2;290(1):228-38
pubmed: 25398882
J Comput Chem. 2011 Jul 30;32(10):2319-27
pubmed: 21500218
J Am Chem Soc. 2012 Jan 25;134(3):1543-52
pubmed: 22191854
Soft Matter. 2014 May 7;10(17):3048-54
pubmed: 24695575
Nature. 1981 Jan 29;289(5796):366-73
pubmed: 7464906
Nat Commun. 2021 Nov 15;12(1):6594
pubmed: 34782611
Chem Phys Lipids. 2014 Jul;181:40-55
pubmed: 24704587
Sci Rep. 2020 Nov 18;10(1):20082
pubmed: 33208852
Biophys J. 2006 Feb 1;90(3):915-26
pubmed: 16272437
Front Mol Biosci. 2022 Jan 27;9:826366
pubmed: 35155580
Biofizika. 1983 Mar-Apr;28(2):242-7
pubmed: 6849992
J Phys Chem B. 2017 Feb 23;121(7):1640-1648
pubmed: 28125233
J Cell Biol. 1998 Mar 23;140(6):1369-82
pubmed: 9508770
Nat Rev Mol Cell Biol. 2008 Feb;9(2):112-24
pubmed: 18216768
Annu Rev Biophys. 2018 May 20;47:153-173
pubmed: 29494252
Nat Microbiol. 2016 Apr 18;1(6):16050
pubmed: 27572837
Sci Rep. 2016 Jun 15;6:28099
pubmed: 27302370
Viruses. 2012 Jul;4(7):1144-68
pubmed: 22852045
J Biol Chem. 2006 Mar 3;281(9):5760-70
pubmed: 16407195
Biochim Biophys Acta. 2003 May 2;1612(1):41-51
pubmed: 12729928
Traffic. 2016 Jun;17(6):593-614
pubmed: 26935856
J Chem Theory Comput. 2014 Feb 11;10(2):865-879
pubmed: 24803855
Adv Exp Med Biol. 2017;966:37-54
pubmed: 27966108
Biophys J. 2012 Jun 20;102(12):2751-60
pubmed: 22735525
Proc Natl Acad Sci U S A. 1999 Aug 3;96(16):8967-72
pubmed: 10430879
PLoS Comput Biol. 2010 Jun 24;6(6):e1000829
pubmed: 20585620
Biochim Biophys Acta. 2003 Jul 11;1614(1):104-15
pubmed: 12873771
Nature. 2020 Jul;583(7814):150-153
pubmed: 32461688
Biophys J. 2003 Sep;85(3):1611-23
pubmed: 12944277
Nature. 1994 Sep 1;371(6492):37-43
pubmed: 8072525
Biochim Biophys Acta Gen Subj. 2017 Feb;1861(2):97-105
pubmed: 27825831
Nat Commun. 2022 Dec 5;13(1):7336
pubmed: 36470871
J Phys Chem B. 2015 Jun 25;119(25):7882-93
pubmed: 25996559
J Chem Inf Model. 2015 Apr 27;55(4):795-805
pubmed: 25826469
Biophys J. 1996 May;70(5):2275-86
pubmed: 9172751
J Chem Theory Comput. 2017 May 9;13(5):2352-2366
pubmed: 28376619
Biopolymers. 2013 Mar;99(3):189-95
pubmed: 23015412
Phys Rev Lett. 1989 Sep 18;63(12):1195-1198
pubmed: 10040500
PLoS One. 2012;7(6):e38302
pubmed: 22761674
J Am Chem Soc. 2015 Jun 24;137(24):7548-51
pubmed: 26039158
Proc Natl Acad Sci U S A. 2020 Mar 31;117(13):7200-7207
pubmed: 32188780
J Biol Chem. 1987 May 15;262(14):6500-5
pubmed: 3571268
J Magn Reson. 2015 Apr;253:154-65
pubmed: 25797012
Chem Sci. 2022 Feb 23;13(12):3437-3446
pubmed: 35432859
J Am Chem Soc. 2010 May 19;132(19):6710-8
pubmed: 20411937
J Cell Sci. 2018 Aug 10;132(4):
pubmed: 29967032
J Biomol NMR. 2013 Feb;55(2):139-46
pubmed: 23329392
Proc Natl Acad Sci U S A. 2019 Feb 12;116(7):2571-2576
pubmed: 30700547

Auteurs

Michal Michalski (M)

Centre of New Technologies, University of Warsaw, Warsaw, Poland.

Piotr Setny (P)

Centre of New Technologies, University of Warsaw, Warsaw, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH